Olaparib routine clinical practice in Germany - Quality of life interim results of the non-interventional C-PATROL study

被引：0
|
作者：
El-Balat, A. [1 ]
Marme, F. [2 ]
Sehouli, J. [3 ]
Welslau, M. [4 ]
Grabowski, J. P. [5 ,6 ]
Hartkopf, A. [7 ]
Glowik, R. [8 ]
Hilpert, F. [9 ]
机构：
[1] Univ Klinikum Frankfurt, Klin Frauenheilkunde & Geburtshilfe, Frankfurt, Germany
[2] Univ Med Ctr Mannheim, Med Fac Mannheim, Dept Gynecol, Mannheim, Germany
[3] Charite, Ctr Oncol Surg, Dept Gynecol, Berlin, Germany
[4] Med Off Hematooncol, Aschaffenburg, Aschaffenburg, Germany
[5] Charite, Dept Gynecol, Berlin, Germany
[6] Charite, Ctr Oncol Surg, Berlin, Germany
[7] Univ Hosp Tuebingen, Ctr Womens Hlth, Tubingen, Germany
[8] AstraZeneca Germany, Oncol, Wedel, Germany
[9] Jerusalem Hosp Hamburg, Ctr Oncol, Hamburg, Germany
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2020年 / 80卷 / 10期
关键词：
D O I：
10.1055/s-0040-1718133
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P304
引用
收藏
页码：E188 / E188
页数：1
相关论文
共 50 条
  • [41] Effectiveness, Safety and Quality of Life with Tofacitinib Treatment in Adult Patients with Rheumatoid Arthritis Under Routine Clinical Care: First Interim Results from a German Non-Interventional, Prospective, Multi-Center Study
    Behrens, Frank
    Prothmann, Ulrich
    Klopsch, Thilo
    Holst, Ann-Doerthe
    Blindzellner, Lisa
    Behmer, Olaf
    Klaus, Pascal
    Meng, Thomas
    Loeschmann, Peter-Andreas
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [42] Efficacy and Tolerability of Certolizumab pegol for the Treatment of rheumatoid Arthritis in clinical Practice in Germany: 3rd Interim Analysis of non-interventional Study "Fast"
    Burmester, G.
    Mueller-Ladner, U.
    Nuesslein, H.
    von Hinueber, U.
    Edelmann, E.
    Detert, J.
    Hoehle, M.
    Richter, C.
    Klopsch, T.
    Kumke, T.
    Fricke, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 100 - 100
  • [43] Efficacy and safety of tirbanibulin in actinic keratoses. Interim results of a non-interventional study
    Heppt, M.
    Hadshiew, I.
    Kempf, A.
    Melzer, A.
    Berking, C.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 69 - 70
  • [44] Interim results of the phase IV JAKoMo trial, a prospective, non-interventional study of symptoms and quality of life in myelofibrosis patients receiving ruxolitinib therapy
    Wehrle, J.
    Geer, T.
    Brudler, O.
    Schaefer, E.
    Tesch, H.
    Cavanna, D.
    Bachhuber, P.
    Markhauser, M.
    Koschmieder, S.
    Mesa, R. A.
    Pahl, H. L.
    Oncology Research and Treatment, 2015, 38 : 227 - 228
  • [45] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI - Interim results of the non-interventional AIO study QoLiTrap
    von Moos, R.
    Derigs, G.
    Scholten, F.
    Thaler, J.
    Losem, C.
    Kroening, H.
    Windemuth-Kieselbach, C.
    Hofheinz, R. D.
    ANNALS OF ONCOLOGY, 2017, 28
  • [46] Analysis of the quality of life in patients treated with Aflibercept and FOLFIRI for metastatic colorectal cancer (mCRC) - Interim results from the non-interventional QoLiTrap study
    Derigs, H. -G
    Scholten, F.
    Losem, C.
    Kroening, H.
    Windemuth-Kieselbach, C.
    Hofheinz, R. -D
    Oncology Research and Treatment, 2015, 38 : 61 - 62
  • [47] Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI: Interim results of the non-interventional AIO study QoLiTrap
    Zahn, M.
    Scholten, F.
    von Moos, R.
    Thaler, J.
    Hofheinz, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [48] Efficacy of Afatinib in the clinical practice - first results of the GIDEON trial: a prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany
    Rawluk, J.
    Reck, M.
    Laack, E.
    Griesinger, F.
    Schaefer, H.
    Kortsik, C.
    Gaska, T.
    Krueger, S.
    Kokowski, K.
    Budweiser, S.
    Schueler, A.
    Hoffmann, C.
    Brueckl, W.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 210 - 211
  • [49] Efficacy of afatinib in the clinical practice: First results of the GIDEON trial: A prospective non-interventional study (NIS) in EGFR mutated NSCLC in Germany
    Brueckl, M.
    Laack, E.
    Reck, M.
    Griesinger, F.
    Schaefer, H.
    Kortsik, C.
    Gaska, T.
    Rawluk, J.
    Krueger, S.
    Kokowski, K.
    Budweiser, S.
    Schueler, A.
    Kiessling, S.
    ANNALS OF ONCOLOGY, 2018, 29 : 524 - 524
  • [50] 2016 Interim analysis of the prospective, non-interventional study JAKoMo: new insights into ruxolitinib treatment of myelofibrosis in daily clinical routine
    Geer, T.
    Heinrich, B.
    Jacobasch, L.
    Tesch, H.
    Wehmeyer, J.
    Schlag, R.
    Groeschl, B.
    Markhauser, M.
    Bachhuber, P.
    Koschmieder, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 149 - 149
12345